MarginsXMarginsX
Home › Markets › Industrials › MTD

Mettler-Toledo International Inc. (MTD)

MTD trades on NYSE in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1727.26
-0.67% on the day
Market cap
$34.4B
Large cap
Revenue · 2025
$4.0B
+4.0% on 2024
Net income · 2025
$869.2M
21.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1037646/000103764626000011/0001037646-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMTD on NYSE
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountrySwitzerland
IPO year1997
SEC CIK0001037646
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$4.0B
Net income$869.2M
Operating incomeNot in SEC XBRL data
Net margin21.6%
Operating marginOperating income not reported
Revenue growth+4.0%
Cash$66.9M
Total assets$3.7B
P/E (computed)39.5×
P/S (computed)8.5×

Warning signs

Cash runway
Cash-flow positive
$52.2M cash at September 30, 2026
Share count, 1 year
-2.6%
2025-09-30 to 2026-09-30 · -7.4% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
-$35.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$52.2M cash; operating cash flow $246.1M a quarter.Report 2026-09-30
Shares outstanding19,890,405 (2026-09-30); 20,428,445 a year earlier; 21,478,705 three years earlier.Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Columbus, Ohio, United StatesPCAOB Form AP 2026-02-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $35.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.1B$246.0M$308.6M$52.2M$2.0B$4.2B10-Q 2026-11-06
Q2 2026
2026-06-30
$1.0B$232.9M$310.4M$51.4M$2.0B$4.1B10-Q 2026-07-31
Q1 2026
2026-03-31
$947.1M$169.5M$139.8M$60.6M$2.2B$4.1B10-Q 2026-05-08
Q4 2025
2025-12-31
$1.1B$285.8M$225.6M$66.9M$2.1B$4.0B10-K 2026-02-06
Q3 2025
2025-09-30
$1.0B$217.5M$299.4M$69.1M$2.1B$3.9B10-Q 2026-11-06
Q2 2025
2025-06-30
$983.2M$202.3M$236.4M$61.8M$2.1B$3.9B10-Q 2026-07-31
Q1 2025
2025-03-31
$883.7M$163.6M$194.4M$64.3M$1.9B$3.8B10-Q 2026-05-08
Q4 2024
2024-12-31
$1.0B$252.3M$266.2M$59.4M$1.8B$3.9B10-K 2026-02-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-02-06
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-03-18

Source: SEC EDGAR submissions feed, 1,006 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.0%
1 month+8.8%
3 months+21.5%
Year to date+24.7%
1 year+23.1%
From 52-week high-1.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
WATWaters Corporation$453.42-1.48%$44.6B
AAgilent Technologies Inc.$172.92-0.60%$48.8B
RVTYRevvity Inc.$148.85-3.59%$16.6B
AVTRAvantor Inc.$15.32-1.42%$10.4B
BIOBio-Rad Laboratories Inc.$360.26-1.67%$9.7B
BRKRBruker Corporation$60.62-1.57%$9.3B
TXG10x Genomics Inc.$54.99-5.50%$7.2B
ALMRAlamar Biosciences Inc.$30.55-0.84%$2.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier